JP2015515462A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015515462A5 JP2015515462A5 JP2015501731A JP2015501731A JP2015515462A5 JP 2015515462 A5 JP2015515462 A5 JP 2015515462A5 JP 2015501731 A JP2015501731 A JP 2015501731A JP 2015501731 A JP2015501731 A JP 2015501731A JP 2015515462 A5 JP2015515462 A5 JP 2015515462A5
- Authority
- JP
- Japan
- Prior art keywords
- blood
- pegylated
- composition
- subject
- albumin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 claims 15
- 102000004506 Blood Proteins Human genes 0.000 claims 12
- 108010017384 Blood Proteins Proteins 0.000 claims 12
- 239000000203 mixture Substances 0.000 claims 11
- 210000004369 blood Anatomy 0.000 claims 9
- 239000008280 blood Substances 0.000 claims 9
- 102000009027 Albumins Human genes 0.000 claims 8
- 108010088751 Albumins Proteins 0.000 claims 8
- 239000003963 antioxidant agent Substances 0.000 claims 4
- 230000003078 antioxidant effect Effects 0.000 claims 3
- 208000007056 sickle cell anemia Diseases 0.000 claims 3
- 239000012503 blood component Substances 0.000 claims 2
- 239000003914 blood derivative Substances 0.000 claims 2
- 230000006378 damage Effects 0.000 claims 2
- 210000003743 erythrocyte Anatomy 0.000 claims 2
- 238000001356 surgical procedure Methods 0.000 claims 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims 1
- 102000001554 Hemoglobins Human genes 0.000 claims 1
- 108010054147 Hemoglobins Proteins 0.000 claims 1
- 208000032843 Hemorrhage Diseases 0.000 claims 1
- 208000032456 Hemorrhagic Shock Diseases 0.000 claims 1
- 206010049771 Shock haemorrhagic Diseases 0.000 claims 1
- 230000000740 bleeding effect Effects 0.000 claims 1
- 238000010790 dilution Methods 0.000 claims 1
- 239000012895 dilution Substances 0.000 claims 1
- 239000002086 nanomaterial Substances 0.000 claims 1
- 239000007800 oxidant agent Substances 0.000 claims 1
- 230000001590 oxidative effect Effects 0.000 claims 1
- 230000001737 promoting effect Effects 0.000 claims 1
- 239000003642 reactive oxygen metabolite Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261613105P | 2012-03-20 | 2012-03-20 | |
| US61/613,105 | 2012-03-20 | ||
| PCT/US2013/030355 WO2013142135A1 (en) | 2012-03-20 | 2013-03-12 | Method of enhancing efficacy of blood transfusions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015515462A JP2015515462A (ja) | 2015-05-28 |
| JP2015515462A5 true JP2015515462A5 (https=) | 2016-04-21 |
Family
ID=49223191
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015501731A Pending JP2015515462A (ja) | 2012-03-20 | 2013-03-12 | 輸血の有効性を高める方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US8859499B2 (https=) |
| EP (1) | EP2827887A4 (https=) |
| JP (1) | JP2015515462A (https=) |
| BR (1) | BR112014023200A2 (https=) |
| CL (1) | CL2014002464A1 (https=) |
| HK (1) | HK1204267A1 (https=) |
| IN (1) | IN2014MN02089A (https=) |
| MX (1) | MX2014011186A (https=) |
| WO (1) | WO2013142135A1 (https=) |
| ZA (1) | ZA201407616B (https=) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017120461A1 (en) | 2016-01-08 | 2017-07-13 | The Board Of Trustees Of The Leland Stanford Junior University | Ccr3 modulation in the treatment of aging-associated impairments, and compositions for practicing the same |
| US20160208011A1 (en) | 2010-01-28 | 2016-07-21 | The Board Of Trustees Of The Leland Stanford Junior University | Ccr3 modulation in the treatment of aging-associated impairments, and compositions for practicing the same |
| US10487148B2 (en) | 2010-01-28 | 2019-11-26 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for treating aging-associated impairments |
| US9161968B2 (en) | 2011-04-08 | 2015-10-20 | The Board Of Trustees Of The Leland Stanford Junior University | Methods of neuroprotection involving macrophage colony stimulating factor receptor agonists |
| EP2827887A4 (en) | 2012-03-20 | 2016-04-20 | Einstein Coll Med | METHOD FOR IMPROVING THE EFFECTIVENESS OF BLOOD TRANSFUSIONS |
| US10905779B2 (en) | 2013-12-09 | 2021-02-02 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for screening human blood products comprising plasma using immunocompromised rodent models |
| MX2016007492A (es) * | 2013-12-09 | 2017-03-06 | Univ Leland Stanford Junior | Métodos y composiciones para el tratamiento de afecciones asociadas con el envejecimiento. |
| WO2016077825A1 (en) * | 2014-11-14 | 2016-05-19 | Aima Biotech | Conjugated proteins |
| WO2016083331A1 (en) | 2014-11-25 | 2016-06-02 | Nanobiotix | Pharmaceutical composition, preparation and uses thereof |
| EP3096160B1 (en) * | 2015-05-20 | 2020-02-26 | Veoneer Sweden AB | An fmcw vehicle radar system |
| MA43100A (fr) | 2015-05-28 | 2018-09-05 | Nanobiotix | Nanoparticules à utiliser en tant que vaccin thérapeutique |
| KR20240025721A (ko) | 2015-06-15 | 2024-02-27 | 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 | 노화와 연관된 질환을 치료하기 위한 방법 및 조성물 |
| WO2017083281A1 (en) * | 2015-11-09 | 2017-05-18 | Albert Einstein College Of Medicine, Inc. | Method of ameliorating side effects of sickle cell disease treatments |
| WO2017103914A1 (en) | 2015-12-17 | 2017-06-22 | Regentis Biomaterials Ltd. | Ready for use organic solvent free compositions comprising protein-polymer conjugates and uses thereof |
| ES2900302T3 (es) | 2016-04-28 | 2022-03-16 | Alkahest Inc | Fracciones de plasma como terapia para el crecimiento y la progresión del tumor |
| EA039316B1 (ru) | 2016-10-24 | 2022-01-12 | Алкахест, Инк. | Фракции плазмы крови в качестве лечения когнитивных расстройств, связанных со старением |
| US11040068B2 (en) | 2017-04-26 | 2021-06-22 | Alkahest, Inc. | Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products |
| WO2018200560A1 (en) | 2017-04-26 | 2018-11-01 | Alkahest, Inc. | Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products |
| US11504417B2 (en) | 2017-07-18 | 2022-11-22 | VirTech Bio, Inc. | Blood substitutes comprising hemoglobin and methods of making |
| CN119345230A (zh) | 2018-10-26 | 2025-01-24 | 万能溶剂有限公司 | 血浆和血浆组分用于改善疼痛的用途 |
| JP7773169B2 (ja) * | 2021-02-24 | 2025-11-19 | 学校法人 中央大学 | ポリオキサゾリン結合アルブミン、人工血漿増量剤及び出血ショックの蘇生液 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4267269A (en) * | 1980-02-05 | 1981-05-12 | Baxter Travenol Laboratories, Inc. | Red cell storage solution |
| JPS56139419A (en) * | 1980-03-31 | 1981-10-30 | Kuraray Co Ltd | Erythrocytic preservative and erythrocytic pharmaceutical for preservation |
| US6129912A (en) * | 1997-09-26 | 2000-10-10 | Uab Research Foundation | Polyethylene glycol-protein compositions which reduce the antigenic display of red blood cells |
| ATE256474T1 (de) * | 1998-09-25 | 2004-01-15 | Oklahoma Med Res Found | Hemmung der sichelbildung von erythrozyten mittels n-l-alpha-aspartyl-l-phenylalanine 1- methylester |
| US6251927B1 (en) * | 1999-04-20 | 2001-06-26 | Medinox, Inc. | Methods for treatment of sickle cell anemia |
| US6875423B1 (en) * | 1999-09-21 | 2005-04-05 | Marcos Intaglietta | Methods for increasing peripheral blood circulation |
| EP2292657A1 (en) * | 1999-11-12 | 2011-03-09 | Baxter Biotech Technology S.A.R.L. | Reduced side-effect hemoglobin compositions |
| US6811778B2 (en) | 2001-09-10 | 2004-11-02 | Biopure Corporation | Method for improving oxygen transport by stored red blood cells |
| US20080194481A1 (en) | 2001-12-21 | 2008-08-14 | Human Genome Sciences, Inc. | Albumin Fusion Proteins |
| US7144989B2 (en) * | 2002-03-25 | 2006-12-05 | Albert Einstein College Of Medicine Of Yeshiva University | Pegylated non-hypertensive hemoglobins, methods of preparing same, and uses thereof |
| US7521174B2 (en) * | 2003-12-05 | 2009-04-21 | Albert Einstein College Of Medicine Of Yeshiva University | Universal red blood cells, methods of preparing same, and uses thereof |
| AU2005311251A1 (en) * | 2004-12-01 | 2006-06-08 | Devgen Nv | 5-carboxamido substituted thiazole derivatives that interact with ion channels, in particular with ion channels from the Kv family |
| US8741832B2 (en) * | 2005-06-10 | 2014-06-03 | Albert Einstein College Of Medicine Of Yeshiva University | Pegylated albumin and uses thereof |
| US8071546B2 (en) * | 2005-06-10 | 2011-12-06 | La Jolla Bioengineering Institute | Uses of pegylated albumin |
| CN102300555B (zh) * | 2009-01-30 | 2015-06-17 | 卡斯伯特·O·辛普金斯 | 复苏液 |
| US8815297B2 (en) * | 2009-03-31 | 2014-08-26 | Duke University | Modulation of beta 2 adrenergic receptors by inhibitors of EGLN3 or pVHL |
| KR102170375B1 (ko) * | 2009-06-09 | 2020-10-27 | 프로롱 파마슈티컬스, 엘엘씨 | 헤모글로빈 조성물 |
| US20110189166A1 (en) * | 2010-01-29 | 2011-08-04 | John Boucher | Methods of treating hemorheologic abnormalities in mammals |
| US20130231287A1 (en) * | 2010-02-25 | 2013-09-05 | Parimala Nacharaju | Pegylated albumin polymers and uses thereof |
| EP2827887A4 (en) | 2012-03-20 | 2016-04-20 | Einstein Coll Med | METHOD FOR IMPROVING THE EFFECTIVENESS OF BLOOD TRANSFUSIONS |
| WO2016077825A1 (en) | 2014-11-14 | 2016-05-19 | Aima Biotech | Conjugated proteins |
-
2013
- 2013-03-12 EP EP13764824.2A patent/EP2827887A4/en not_active Withdrawn
- 2013-03-12 IN IN2089MUN2014 patent/IN2014MN02089A/en unknown
- 2013-03-12 WO PCT/US2013/030355 patent/WO2013142135A1/en not_active Ceased
- 2013-03-12 BR BR112014023200A patent/BR112014023200A2/pt not_active IP Right Cessation
- 2013-03-12 US US13/794,978 patent/US8859499B2/en active Active
- 2013-03-12 JP JP2015501731A patent/JP2015515462A/ja active Pending
- 2013-03-12 MX MX2014011186A patent/MX2014011186A/es unknown
- 2013-03-12 HK HK15104771.0A patent/HK1204267A1/xx unknown
-
2014
- 2014-08-07 US US14/454,059 patent/US9498537B2/en active Active
- 2014-09-17 CL CL2014002464A patent/CL2014002464A1/es unknown
- 2014-10-20 ZA ZA2014/07616A patent/ZA201407616B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015515462A5 (https=) | ||
| Li et al. | Scaffold-facilitated locomotor improvement post complete spinal cord injury: Motor axon regeneration versus endogenous neuronal relay formation | |
| JP2014520142A5 (https=) | ||
| JP2011088927A5 (https=) | ||
| NZ592837A (en) | Antidotes for factor xa inhibitors and methods of using the same in combination with blood coagulating agents | |
| CN102406205B (zh) | 牡蛎多糖果汁饮料 | |
| JP2017505761A5 (https=) | ||
| JP2017532343A5 (https=) | ||
| RU2017116973A (ru) | Способы применения и композиции нейрегулинов для предотвращения, лечения или замедления сердечной недостаточности с сохраненной фракцией выброса | |
| MX387845B (es) | Polímeros enlazados al proton para administracion oral. | |
| JP2012528890A5 (https=) | ||
| Lieder et al. | Cardioprotection by post-conditioning with exogenous triiodothyronine in isolated perfused rat hearts and isolated adult rat cardiomyocytes | |
| BR112018072714A2 (pt) | composições de ligação a hcl para e método de tratamento de distúrbios de ácido-base | |
| RU2018123666A (ru) | Способ лечения рака у млекопитающего, включая человека, с примененим деплеции метионина и аспарагина | |
| JP2017522288A5 (https=) | ||
| Kelly et al. | TNF receptor 2, not TNF receptor 1, enhances mesenchymal stem cell-mediated cardiac protection following acute ischemia | |
| JP2016513523A5 (https=) | ||
| CN105400214A (zh) | 一种使用透明质酸交联明胶制备止血棉的方法 | |
| Ali et al. | HORMONAL INDUCTION OF OVARIAN CYCLICITY AND CONCEPTION RATE IN POSTPARTUM ANESTRUS BUFFALOES. | |
| CN107137700B (zh) | 一种基于干细胞源外泌体的组合物及其在制备治疗心肌梗死的药物中的应用 | |
| JP2015532293A5 (ja) | 糖尿病患者における心不全の治療用組成物 | |
| JP2017525704A5 (https=) | ||
| Schmidt et al. | Remote ischemic conditioning: the cardiologist's perspective | |
| JP2016534062A5 (https=) | ||
| EP2525819A4 (en) | IMMUNOTHERAPY COMPOSITIONS AND TREATMENT PROCEDURES |